NEW YORK, Aug. 28 – Software developer BioDiscovery said Tuesday that it had granted a site license for its GeneSight software to the Torrey Mesa Research Institute.
GeneSight is designed to allow researchers to analyze gene expression data, combining various statistical tools and visualization capabilities.Â
"Our microarray facility produces a vast amount of expression data daily, and hosts one of the largest expression databases in agricultural genomics. We need a comprehensive statistical analysis tool that is easy to use and platform independent for our large-scale data analysis projects," Tong Zhu, head of TMRI’s microarray group, said in a statement.Â
TMRI of San Diego is a wholly owned subsidiary of Syngenta, an agribusiness.
In addition to GeneSight, BioDiscovery of Marina Del Rey, Calif., also sells ImaGene, a microarray image processing and analysis tool for microarrays, and CloneTracker, a data management program used for microarray fabrication and production.
BioDiscovery did not disclose the financial terms for the site license.